FCGR3A and neoplasm: Various stimulatory conditions were used to assess NK cell responsiveness including stimulation with the tumor cell line K562, with anti-CD16 monoclonal antibodies, with a mix of IL-12 and IL-18 inflammatory cytokines, or with PMA and ionomycin (Figure 4E).